Voya Investment Management LLC Has $4.20 Million Stake in DaVita Inc. $DVA

Voya Investment Management LLC lowered its stake in shares of DaVita Inc. (NYSE:DVA) by 3.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,421 shares of the company’s stock after selling 940 shares during the quarter. Voya Investment Management LLC’s holdings in DaVita were worth $4,195,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in DVA. UMB Bank n.a. grew its position in DaVita by 65.5% during the first quarter. UMB Bank n.a. now owns 192 shares of the company’s stock worth $29,000 after buying an additional 76 shares in the last quarter. Copia Wealth Management acquired a new stake in DaVita during the fourth quarter worth approximately $30,000. National Pension Service grew its position in DaVita by 74.3% during the first quarter. National Pension Service now owns 197 shares of the company’s stock worth $30,000 after buying an additional 84 shares in the last quarter. Y.D. More Investments Ltd acquired a new stake in DaVita during the first quarter worth approximately $35,000. Finally, NewEdge Advisors LLC grew its position in DaVita by 20.8% during the first quarter. NewEdge Advisors LLC now owns 511 shares of the company’s stock worth $78,000 after buying an additional 88 shares in the last quarter. Institutional investors and hedge funds own 90.12% of the company’s stock.

Insider Buying and Selling

In other DaVita news, insider James O. Hearty sold 2,351 shares of the business’s stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the sale, the insider directly owned 26,038 shares of the company’s stock, valued at approximately $3,905,700. The trade was a 8.28% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

DVA has been the topic of a number of research analyst reports. Truist Financial set a $148.00 target price on DaVita in a report on Friday, August 8th. Barclays reduced their target price on DaVita from $169.00 to $160.00 and set an “equal weight” rating on the stock in a report on Thursday, August 7th. Bank of America reduced their target price on DaVita from $145.00 to $140.00 and set an “underperform” rating on the stock in a report on Wednesday, September 10th. Finally, Wall Street Zen raised DaVita from a “hold” rating to a “buy” rating in a report on Saturday, September 13th. Three analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, DaVita currently has a consensus rating of “Reduce” and an average price target of $158.00.

DaVita Stock Performance

DVA stock opened at $129.94 on Friday. The stock has a 50-day moving average price of $137.15 and a 200-day moving average price of $141.01. DaVita Inc. has a 1-year low of $126.07 and a 1-year high of $179.60. The company has a current ratio of 1.39, a quick ratio of 1.34 and a debt-to-equity ratio of 23.18. The firm has a market cap of $9.29 billion, a PE ratio of 12.78, a price-to-earnings-growth ratio of 0.93 and a beta of 1.13.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, topping the consensus estimate of $2.70 by $0.25. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The firm had revenue of $3.38 billion during the quarter, compared to analyst estimates of $3.36 billion. During the same period last year, the company posted $2.00 EPS. The business’s quarterly revenue was up 6.1% on a year-over-year basis. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, equities research analysts expect that DaVita Inc. will post 10.76 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.